Inventor · disambiguated record
Thomas D. Aicher
Also filed as: AICHER THOMAS D · AICHER THOMAS DANIEL
53 granted patents·11 pending applications·252 citations·filing 2003–2021
98Inventor score
Top patents by PatentIndex Score
64 records- 0196US7449486B2Mitotic kinesin inhibitors and methods of use thereofARRAY BIOPHARMA INC·Filed 2005·Granted Nov 11, 2008·37 cites·34 claims
- 0294US9394315B2Tetrahydro[1,8]naphthyridine sulfonamide and related compounds for use as agonists of RORγ and the treatment of diseaseLYCERA CORP·Filed 2013·Granted Jul 19, 2016·15 cites·30 claims
- 0392US10221146B2Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of diseaseMERCK SHARP & DOHME·Filed 2017·Granted Mar 5, 2019·6 cites·18 claims
- 0492US9809561B2Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of diseaseMERCK SHARP & DOHME·Filed 2014·Granted Nov 7, 2017·8 cites·16 claims
- 0592US9802958B2Tetrahydro[1,8]naphthyridine sulfonamide and related compounds for use as agonists of RORy and the treatment of diseaseLYCERA CORP·Filed 2016·Granted Oct 31, 2017·7 cites·25 claims
- 0692US9663502B22-Acylamidomethyl and sulfonylamidomethyl benzoxazine carbamates for inhibition of RORgamma activity and the treatment of diseaseMERCK SHARP & DOHME·Filed 2014·Granted May 30, 2017·12 cites·26 claims
- 0792US9657033B2Tetrahydronaphthyridine and related bicyclic compounds for inhibition of RORγ activity and the treatment of diseaseMERCK SHARP & DOHME·Filed 2013·Granted May 23, 2017·20 cites·44 claims
- 0892US9266827B2Bicyclic sulfone compounds for inhibition of RORgamma activity and the treatment of diseaseMERCK SHARP & DOHME·Filed 2013·Granted Feb 23, 2016·23 cites·52 claims
- 0991US10208061B2Tetrahydro[1,8]naphthyridine sulfonamide and related compounds for use as agonists of RORγ and the treatment of diseaseLYCERA CORP·Filed 2017·Granted Feb 19, 2019·6 cites·19 claims
- 1091US9783511B2Carbamate benzoxazine propionic acids and acid derivatives for modulation of RORgamma activity and the treatment of diseaseMERCK SHARP & DOHME·Filed 2014·Granted Oct 10, 2017·9 cites·21 claims
- 1190US9512111B2N-sulfonylated tetrahydroquinolines and related bicyclic compounds for inhibition of RORγ activity and the treatment of diseaseGLICK GARY D·Filed 2011·Granted Dec 6, 2016·21 cites·15 claims
- 1288US7956073B2Mitotic kinesin inhibitors and methods of use thereofARRAY BIOPHARMA INC·Filed 2008·Granted Jun 7, 2011·8 cites·11 claims
- 1387US10377768B2Tetrahydronaphthyridine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of diseaseMERCK SHARP & DOHME·Filed 2017·Granted Aug 13, 2019·6 cites·28 claims
- 1487US9896441B2Tetrahydroquinoline sulfonamide and related compounds for use as agonists of RORγ and the treatment of diseaseLYCERA CORP·Filed 2015·Granted Feb 20, 2018·6 cites·58 claims
- 1587US8236825B2Mitotic kinesin inhibitors and methods of use thereofHANS JEREMY·Filed 2011·Granted Aug 7, 2012·7 cites·24 claims
- 1687US8022222B2Glucokinase activatorsARRAY BIOPHARMA INC·Filed 2007·Granted Sep 20, 2011·7 cites·16 claims
- 1783US8623895B2Mitotic kinesin inhibitors and methods of use thereofHANS JEREMY·Filed 2012·Granted Jan 7, 2014·4 cites·104 claims
- 1883US8022223B22-aminopyridine analogs as glucokinase activatorsARRAY BIOPHARMA INC·Filed 2007·Granted Sep 20, 2011·5 cites·20 claims
- 1982US9102639B2Mitotic kinesin inhibitors and methods of use thereofARRAY BIOPHARMA INC·Filed 2013·Granted Aug 11, 2015·3 cites·22 claims
- 2081US8212045B2Pyridin-2-yl-amino-1, 2, 4-thiadiazole derivatives as glucokinase activators for the treatment of diabetes mellitusAICHER THOMAS DANIEL·Filed 2008·Granted Jul 3, 2012·4 cites·9 claims
- 2180US10442798B2Tetrahydroquinoline sulfonamide and related compounds for use as agonists of RORγ and the treatment of diseaseLYCERA CORP·Filed 2018·Granted Oct 15, 2019·2 cites·30 claims
- 2280US10364237B2Tetrahydroquinoline sulfonamide and related compounds for use as agonists of RORγ and the treatment of diseaseLYCERA CORP·Filed 2017·Granted Jul 30, 2019·2 cites·20 claims
- 2380US7713979B2Cycloalkyl lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1LILLY CO ELI·Filed 2005·Granted May 11, 2010·4 cites·7 claims
- 2479US10421751B2Dihydro-2H-benzo[b][1,4]oxazine sulfonamide and related compounds for use as agonists of RORγ and the treatment of diseaseLYCERA CORP·Filed 2016·Granted Sep 24, 2019·2 cites·26 claims
- 2575US10189777B2Benzenesulfonamido and related compounds for use as agonists of RORγ and the treatment of diseaseLYCERA CORP·Filed 2015·Granted Jan 29, 2019·2 cites·24 claims
- 2675US8362037B22-aminopyridine analogs as glucokinase activatorsARRAY BIOPHARMA INC·Filed 2008·Granted Jan 29, 2013·2 cites·23 claims
- 2775US7384934B2Piperazine substituted aryl benzodiazepinesLILLY CO ELI·Filed 2003·Granted Jun 10, 2008·8 cites·21 claims
- 2875US7214673B2Piperazine substituted aryl benzodiazepines and their use as dopamine receptor antagonists for the treatment of psychotic disordersLILLY CO ELI·Filed 2003·Granted May 8, 2007·9 cites·9 claims
- 2974US9499503B2Mitotic kinesin inhibitors and methods of use thereofARRAY BIOPHARMA INC·Filed 2015·Granted Nov 22, 2016·1 cites·18 claims
- 3073US10611740B2Aryl dihydro-2H-benzo[b][1,4]oxazine sulfonamide and related compounds for use as agonists of RORγ and the treatment of diseaseLYCERA CORP·Filed 2016·Granted Apr 7, 2020·1 cites·44 claims
- 3173US10532088B2Adoptive cellular therapy using an agonist of retinoic acid receptor-related orphan receptor gamma and related therapeutic methodsLYCERA CORP·Filed 2015·Granted Jan 14, 2020·2 cites·37 claims
- 3271US9914706B2N-substituted pyrazolyl guanidine F1F0-ATPase inhibitors and therapeutic uses thereofLYCERA CORP·Filed 2014·Granted Mar 13, 2018·1 cites·26 claims
- 3369US10112935B2Indazolyl thiadiazolamines and related compounds for inhibition of Rho-associated protein kinase and the treatment of diseaseLYCERA CORP·Filed 2016·Granted Oct 30, 2018·1 cites·32 claims
- 3469US8853409B2Pyridin-2yl-amino-1, 2, 4-thiadiazole derivatives as glucokinase activators for the treatment of diabetes mellitusAICHER THOMAS DANIEL·Filed 2012·Granted Oct 7, 2014·1 cites·32 claims
- 3567US7816523B2Potentiators of glutamate receptorsLILLY CO ELI·Filed 2009·Granted Oct 19, 2010·0 cites·18 claims
- 3667US2018334441A1Mitotic kinesin inhibitors and methods of use thereofARRAY BIOPHARMA INC·Filed 2018·Application pending·0 cites
- 3766US7803938B2Potentiators of glutamate receptorsLILLY CO ELI·Filed 2009·Granted Sep 28, 2010·0 cites·15 claims
- 3865US11059796B2Aryl dihydro-2H benzo[b][1,4]oxazine sulfonamide and related compounds for use as agonists of RORγ and the treatment of diseaseUNIV MICHIGAN REGENTS·Filed 2020·Granted Jul 13, 2021·0 cites·20 claims
- 3965US10745364B2Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of diseaseMERCK SHARP & DOHME·Filed 2019·Granted Aug 18, 2020·0 cites·18 claims
- 4063US10017482B2Mitotic kinesin inhibitors and methods of use thereofARRAY BIOPHARMA INC·Filed 2016·Granted Jul 10, 2018·0 cites·15 claims
- 4160US9079890B2Intermediates for the preparation of pyridin-2-yl-amino-1,2,4-thiadiazole derivativesARRAY BIOPHARMA INC·Filed 2014·Granted Jul 14, 2015·0 cites·12 claims
- 4258US7858646B2Potentiators of glutamate receptorsLILLY CO ELI·Filed 2005·Granted Dec 28, 2010·0 cites·23 claims
- 4358US7678794B2Potentiators of glutamate receptorsLILLY CO ELI·Filed 2005·Granted Mar 16, 2010·0 cites·19 claims
- 4457US7598423B2Potentiators of glutamate receptorsLILLY CO ELI·Filed 2005·Granted Oct 6, 2009·0 cites·23 claims
- 4555US8883828B22-aminopyridine analogs as glucokinase activatorsARRAY BIOPHARMA INC·Filed 2012·Granted Nov 11, 2014·0 cites·11 claims
- 4655US8431713B22-aminopyridine derivatives as glucokinase activatorsAICHER THOMAS DANIEL·Filed 2008·Granted Apr 30, 2013·0 cites·2 claims
- 4755US2023295119A1Substituted pyridines for the treatment of inflammatory diseasesGOSSAMER BIO SERVICES INC·Filed 2021·Application pending·0 cites
- 4852US10392350B2N-substituted pyrazolyl guanidine F1F0-ATPase inhibitors and therapeutic uses thereofLYCERA CORP·Filed 2018·Granted Aug 27, 2019·0 cites·21 claims
- 4952US8354540B22-aminopyridine analogs as glucokinase activatorsARRAY BIOPHARMA INC·Filed 2011·Granted Jan 15, 2013·0 cites·18 claims
- 5051US10556898B2Indazolyl-1,2,4-thiadiazolamines and related compounds for inhibition of Rho-associated protein kinase and the treatment of diseaseLYCERA CORP·Filed 2019·Granted Feb 11, 2020·0 cites·31 claims
Showing the top 50 of 64 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →